{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T17:56:55Z","timestamp":1769363815508,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.vaccine.2019.10.050","type":"journal-article","created":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T00:28:54Z","timestamp":1573000134000},"page":"655-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0007-3229","authenticated-orcid":false,"given":"Lynda","family":"Mottram","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lundgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Mari","family":"Svennerholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susannah","family":"Leach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.10.050_b0005","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.1016\/j.vaccine.2017.06.006","article-title":"Cross-reactivity and avidity of antibody responses induced in humans by the oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine ETVAX","volume":"35","author":"Leach","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0010","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-065X.2012.01124.x","article-title":"Germinal center selection and the development of memory B and plasma cells","volume":"247","author":"Shlomchik","year":"2012","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2019.10.050_b0015","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.1998.00423.x","article-title":"Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation","volume":"93","author":"Gonzales-Fernandez","year":"2001","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2019.10.050_b0020","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1093\/infdis\/jiw237","article-title":"Fractional third and fourth dose of RTS, S\/AS01 malaria candidate vaccine: aphase 2a controlled human malaria parasite infection and immunogenicity study","volume":"214","author":"Regules","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.050_b0025","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.1016\/j.vaccine.2006.06.051","article-title":"Sense and the science of childhood immunization: can we achieve more with less?","volume":"24","author":"Obaro","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0030","doi-asserted-by":"crossref","first-page":"e342","DOI":"10.1371\/journal.pntd.0000342","article-title":"Immunogenicity of fractional doses of tetravalent A\/C\/Y\/W135 meningococcal polysaccharide vaccine: results from a randomized non-inferiority controlled trial in Uganda","volume":"2","author":"Guerin","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.10.050_b0035","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.10.050_b0040","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1586\/erv.12.12","article-title":"Recent progress toward an enterotoxigenic Escherichia coli vaccine","volume":"11","author":"Svennerholm","year":"2012","journal-title":"Exp Rev Vacc"},{"key":"10.1016\/j.vaccine.2019.10.050_b0045","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.vaccine.2014.11.049","article-title":"An assessment of enterotoxigenic Escherichia coli and Shigella vaccine candidates for infants and children","volume":"33","author":"Walker","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0050","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2013.03.027","volume":"31","author":"Holmgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0055","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0060","article-title":"Evaluation of the safety and immunogenicity of the oral inactivated enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants in a double-blind, randomized, placebo-controlled Phase I\/II trial","author":"Qadri","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.050_b0065","doi-asserted-by":"crossref","first-page":"e51718","DOI":"10.1371\/journal.pone.0051718","article-title":"The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens","volume":"7","author":"Leach","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.10.050_b0070","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.4049\/jimmunol.1401633","article-title":"Cholera toxin, and the related nontoxic adjuvants mmCT and dmLT, promote human Th17 responses via cyclic AMP-protein kinase A and inflammasome-dependent IL-1 signaling","volume":"194","author":"Larena","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2019.10.050_b0075","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1016\/j.vaccine.2005.07.022","article-title":"Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers","volume":"24","author":"Carpenter","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0080","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1016\/j.vaccine.2009.05.005","article-title":"Parallel analysis of mucosally derived B- and T-cell responses to an oral typhoid vaccine using simplified methods","volume":"27","author":"Lundgren","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0085","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0090","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1128\/CVI.05342-11","volume":"18","author":"Harro","year":"2011","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2019.10.050_b0095","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/nprot.2013.058","article-title":"Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood","volume":"8","author":"Saletti","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.vaccine.2019.10.050_b0100","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1016\/j.vaccine.2016.04.055","article-title":"Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine","volume":"34","author":"Lundgren","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0105","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1016\/j.vaccine.2013.04.066","article-title":"Different kinetics of circulating antibody-secreting cell responses after primary and booster oral immunizations: a tool for assessing immunological memory","volume":"31","author":"Leach","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0110","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0022-1759(93)90369-I","article-title":"The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity","volume":"166","author":"Goldblatt","year":"1993","journal-title":"J Immunol Meth"},{"key":"10.1016\/j.vaccine.2019.10.050_b0115","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0264-410X(97)00169-2","article-title":"Safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli vaccine","volume":"16","author":"Jertborn","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0120","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure on JSTOR","volume":"6","author":"Holm","year":"1979","journal-title":"Scand J Stat"},{"key":"10.1016\/j.vaccine.2019.10.050_b0125","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/nm.1894","article-title":"Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease","volume":"15","author":"Delgado","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2019.10.050_b0130","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/520200","article-title":"Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity","volume":"29","author":"Romero-Steiner","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2019.10.050_b0135","doi-asserted-by":"crossref","first-page":"e2822","DOI":"10.1371\/journal.pntd.0002822","article-title":"Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults","volume":"8","author":"Alam","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2019.10.050_b0140","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1128\/CVI.00521-12","article-title":"Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection","volume":"20","author":"Alam","year":"2013","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2019.10.050_b0145","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1128\/CVI.00341-13","article-title":"Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine","volume":"20","author":"Alam","year":"2013","journal-title":"Clin Vacc Immunol"},{"key":"10.1016\/j.vaccine.2019.10.050_b0150","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1016\/j.vaccine.2018.11.040","volume":"37","author":"Akhtar","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0155","series-title":"Approaches to enhance and evaluate the immunogenicity of an oral ETEC vaccine","author":"Leach","year":"2015"},{"key":"10.1016\/j.vaccine.2019.10.050_b0160","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1016\/j.vaccine.2016.02.076","article-title":"Status of vaccine research and development for enterotoxigenic Escherichia coli","volume":"34","author":"Bourgeois","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.10.050_b0165","unstructured":"European Medicines Agency. Dukoral. EMA; 2015."},{"key":"10.1016\/j.vaccine.2019.10.050_b0170","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1086\/421275","article-title":"Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh","volume":"189","author":"Saha","year":"2004","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19314306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:38:14Z","timestamp":1759401494000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19314306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0264410X19314306"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.050","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Booster vaccination with a fractional dose of an oral cholera vaccine induces comparable vaccine-specific antibody avidity as a full dose: A randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.10.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}